Drug shortage
Atropine Sulfate Injection · Fresenius Kabi USA, LLC
FDA drug shortage · Current · updated Apr 1, 2025
Key facts
| Generic name | Atropine Sulfate Injection |
|---|---|
| Proprietary name | Atropine Sulfate |
| Company | Fresenius Kabi USA, LLC |
| Presentation | Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20) |
| Dosage form | Injection |
| Strength | .4 mg/1 mL |
| Status | Current |
| Therapeutic category | Anesthesia Neurology Pediatric |
| Package NDCs | 63323-580-20 |
| First posted | Jan 1, 2012 |
| Last updated | Apr 1, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: